NASDAQ:SGMO

Sangamo Biosciences Stock Insider Trading

etoro logo Buy SGMO
*Your capital is at risk
$0.216
+0.0022 (+1.03%)
At Close: Jun 03, 2026

Sangamo BioSciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 40.46. In total, the insiders bought 6.04M and sold 1.52M SGMO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
40.46
Buy 6.04M shares
Sell 1.52M shares
45% Buy Activity
Moderate Positive Correlation
Sell Signal Low Confidence
Apr 21, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 40.46.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 25, 2026
Sell
Common Stock
F-InKind
Willoughby Scott B.
SVP, Chief Legal Officer, Secy
Officer 4 036
Value: $703
May 25, 2026
Sell
Common Stock
F-InKind
Dubois-stringfellow Nathalie
SVP-chief Development Officer
Officer 4 036
Value: $703
May 25, 2026
Sell
Common Stock
F-InKind
Jain Nikunj
Principal Accounting Officer
Officer 1 919
Value: $334
May 25, 2026
Sell
Common Stock
F-InKind
Davis Gregory D
Head Of Research & Technology
Officer 1 630
Value: $284
May 25, 2026
Sell
Common Stock
F-InKind
Macrae Sandy
President, CEO And Director
CEO / President 12 613
Value: $2K
Apr 22, 2026
Sell
Common Stock
S-Sale
Davis Gregory D
Head Of Research & Technology
Officer 69 827
Value: $17.7K
Apr 21, 2026
Sell
Common Stock
S-Sale
Dubois-stringfellow Nathalie
SVP-chief Development Officer
Officer 345 942
Value: $89.2K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
A-Award
Dubois-stringfellow Nathalie
SVP-chief Development Officer
Officer 800 000
Value: $208.1K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
A-Award
Jain Nikunj
Principal Accounting Officer
Officer 225 000
Value: $58.5K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
A-Award
Davis Gregory D
Head Of Research & Technology
Officer 225 000
Value: $58.5K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
A-Award
Macrae Sandy
President, CEO And Director
CEO / President 2 500 000
Value: $650.3K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
A-Award
Willoughby Scott B.
SVP, Chief Legal Officer, Secy
Officer 800 000
Value: $208.1K
Feb 25, 2026
Sell
Common Stock
F-InKind
Davis Gregory D
Head Of Research & Technology
Officer 5 119
Value: $2K
Feb 25, 2026
Sell
Common Stock
F-InKind
Jain Nikunj
Principal Accounting Officer
Officer 5 119
Value: $2K
Feb 25, 2026
Sell
Common Stock
F-InKind
Dubois-stringfellow Nathalie
SVP-chief Development Officer
Officer 12 354
Value: $6K
Feb 25, 2026
Sell
Common Stock
F-InKind
Macrae Sandy
President, CEO And Director
CEO / President 33 637
Value: $15.8K
Feb 25, 2026
Sell
Common Stock
F-InKind
Willoughby Scott B.
SVP, Chief Legal Officer, Secy
Officer 12 354
Value: $6K
Feb 24, 2026
Sell
Common Stock
F-InKind
Davis Gregory D
Head Of Research & Technology
Officer 832
Value: $393
Feb 24, 2026
Sell
Common Stock
F-InKind
Jain Nikunj
Principal Accounting Officer
Officer 666
Value: $315
Feb 24, 2026
Sell
Common Stock
F-InKind
Dubois-stringfellow Nathalie
SVP-chief Development Officer
Officer 2 063
Value: $975
Feb 24, 2026
Sell
Common Stock
F-InKind
Macrae Sandy
President, CEO And Director
CEO / President 5 291
Value: $2K
Feb 24, 2026
Sell
Common Stock
F-InKind
Willoughby Scott B.
SVP, Chief Legal Officer, Secy
Officer 1 650
Value: $780
Jan 22, 2026
Sell
Common Stock
F-InKind
Dubois-stringfellow Nathalie
SVP-chief Development Officer
Officer 36 676
Value: $14.6K
Jan 22, 2026
Sell
Common Stock
F-InKind
Davis Gregory D
Head Of Research & Technology
Officer 7 721
Value: $3K
Jan 22, 2026
Sell
Common Stock
F-InKind
Macrae Sandy
President, CEO And Director
CEO / President 102 950
Value: $41.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SANGAMO BIOSCIENCES
Sangamo BioSciences
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE